The human bone marrow as an immunoregulatory organ

Transplantation

Volumn 68, Issue 8, 1999, Pages 1079-1090

  Miller, Joshua ^a   Mathew, James ^a   Garcia Morales, Rolando ^a   Zucker, Keith E ^a   Carreno, Manuel ^a   Jin, Yide ^a   Fuller, Laphalle ^a   Burke, George W ^a   Ciancio, Gaetano ^a   Tzakis, Andreas G ^a   Ricordi, Camillo ^a   Olson, Les ^a   Rosen, Anne ^a   Roth, David ^a   Esquenazi, Violet ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID; TACROLIMUS;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOIMMUNITY; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DOWN REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; REVIEW;

ANIMALS; BONE MARROW; BONE MARROW CELLS; FETUS; GRAFT VS HOST DISEASE; HUMANS; IMMUNE SYSTEM; LIVER; MODELS, NEUROLOGICAL; THYMUS GLAND;

EID: 0033610456     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199910270-00001     Document Type: Review

References (103)

1. Burnet FM. The clonal selection theory of acquired immunity. London: Cambridge University Press, 1959.
2. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T cell recognition. Nature 1988; 334: 395.
3. Chen J, Alt FW. Gene rearrangement and B-cell development. Curr Opin Immunol 1993; 5: 194.
4. Felton LD. Significance of antigen in animal tissues. J Immunol 1949; 61: 107.
5. Chase MW. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 1946; 61: 257.
6. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603.
7. Miller JFAP. Effect of neonatal thymectomy on the immunological significance of the thymus. Proc Roy Soc B 1962; 156: 145.
8. Uphoff DE, Press LP, Lieberman R. Genetic factors influencing irradiation protection by bone marrow. V. Multiple allogeneic donors. J Natl Cancer Inst 1965; 35(4): 695.
9. Miller J. Immunological competence: alteration by whole body x-irradiation and shielding of selected lymphoid tissues. Science 1966; 151: 1395.
10. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Sachs DH. Characterization of mixed allogeneic chimeras: immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 1985; 162: 231.
11. Strober S, Dhillon M, Schubert M, et al. Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med 1989; 321: 28.
12. Monaco AP, Clark AW, Wood ML, et al. Possible active enhancement of a human cadaver renal allograft with antilymphocytic serum (ALS) and donor bone marrow: case report of an initial attempt. Surgery 1976; 79: 384.
13. Barber WH, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70.
14. Zeevi A, Pavlick M, Lombardozzi S, et al. Immune status of recipients following bone marrow augmented solid organ transplantation. Transplantation 1995; 59: 616.
15. Ascher NL. Tolerance induction using bone marrow transplantation. Liver Transplant Surg 1998; 4(4): 335.
16. Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation 1993; 56: 461.
17. Modlin RL. Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 1994; 102(6): 828.
18. Fuchs EJ, Matzinger P. Is cancer dangerous to the immune system? Semin Immunol 1996; 8:5: 271.
19. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism and donor specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272.
20. Fontes P, Rao A, Demetris AJ, et al. Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation. Lancet 1994; 1: 151.
21. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microchimerism and allograft survival. Immunol Today 1996; 17: 577.
22. Wood K, Sachs DH. Chimerism and transplant tolerance: cause and effect. Immunol Today 1996; 17: 584.
23. Spriewald BM, Wassmuth R, Carl HD, et al. Microchimerism after liver transplantation: prevalence and methodological aspects of detection. Transplantation 1998; 66:1: 77.
24. Sivasai KS, Alevy YG, Duffy BF et al. Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism. Transplantation 1997; 64:3: 427.
25. Mathew JM, Garcia-Morales R, Carreno M, et al. Chimeric cells of donor phenotype present in living related renal transplant recipients infused with donor marrow: potent regulators of recipient immune responses to the donor. J Leuk Biol 1999 (in press).
26. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273.
27. Nossal GJV, Pike BL. Clonal anergy: persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen. Proc Natl Acad Sci USA 1980; 77: 1602.
28. Thomson A, Lu L, Subbotin VMLY, et al. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Transplantation 1995; 59: 544.
29. Ricordi C, Ildstad ST, Demetris AJ, Abou El-Ezz AY, Murase N, Starzl TE. Donor dendritic cells repopulation in recipients after rat-to-mouse bone-marrow transplantation. Lancet 1992; 1: 1610.
30. Zinkernagel RM, Doherty PC. Restriction of in vivo T-cell mediated cytotoxicity in lymphocytic chorlomeningitis within a syngeneic or semiallogeneic system. Nature 1971; 248: 701.
31. Swain S. T cell subsets and the recognition of MHC class. Immunol Rev 1983; 74: 129.
32. Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373.
33. Mathew JM, Carreno M, Fuller L, et al. In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation. Transplantation 1999; 68: 1172.
34. Faustman DL, Hauptfeld V, Davie JM, Lacy PE. Prolonged survival of donor skin grafts on mice bearing established islet of Langerhans transplants. Transplantation 1985; 40(2): 216.
35. Lafferty K, Prowse S, Simeonovic C, Warren HS. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. In: Paul WE, Fathman CG, Metzgar H, eds. Annu Rev of Immunology. Palo Alto, CA: Annual Reviews, Inc., 1983: 43.
36. Norton JD, Deed RW, Craggs G, Sablitzky F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol 1998; 8(2): 58.
37. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649.
38. Wakayama T, Perry AC, Zuccotti M, Johnson KR, Yanagimachi R. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 1998; 394:6691: 369.
39. Weiss A, Cedar H. The role of DNA demethylation during development. Genes Cells 1997; 2(8): 481.
40. Artavanis-Tsakonas S, Matsuno K, Fortini M. Notch signaling. Science 1995; 268: 225.
41. Li L, Krantz I, Deng Y, Genin A, Banta A, Collins C, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch 1. Nature Genetics 1997; 16: 243.
42. Van Doren M, Bailey A, Esnayra J, Ede K, Posakony J Negative regulation of proneural gene activity: hairy is a direct transcriptional repressor of achaete. Genes Dev 1994; 8: 2729.
43. Lemercier C, To R, Carrasco R, Konieczny S. The basic helix-loop-helix transcription factor Mist 1 functions as a transcriptional repressor of MyoD. EMBO J 1998; 17: 1412.
44. Sasai Y, Kageyama R, Tagawa Y, Shigemoto R, Nakanishi S. Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. Genes Dev 1992; 6: 2620.
45. Benezra R, Davis R, Lockshon D, Turner D, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 1990; 61: 49.
46. Deed R, Jasiok M, Norton J Lymphoid-specific expression of the Id3 gene in hematopoietic cells. Selective antagonism of ELA basic helix-loop-helix protein associated with Id3-induced differentiation of erythroleukemia cells. J Biol Chem 1998; 273: 8278.
47. Heemskerk M, Blom B, Nolan G, et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix-loop-helix factor Id3. J Exp Med 1997; 186: 1597.
48. Brent L, Rayfield LS, Chandler P, Fierz W, Medawar PB, Simpson E. Supposed Lamarckian inheritance of immunological tolerance. Nature 1981; 290:5806: 508.
49. Kaliss N. Immunological enhancement of tumor homografts in mice. A review. Cancer Res 1958; 18: 992.
50. Batchelor JR. The riddle of kidney graft enhancement. Transplantation 1978; 26: 139.
51. Brent L, Opara SC. Specific unresponsiveness to skin allografts in mice. V. Synergy between donor tissue extract, procarbazine hydrochloride, and antilymphocyte serum in creating a long-lasting unresponsiveness mediated by suppressor T cells. Transplantation 1979; 27(2): 120.
52. Eardley DD, Gershon RK. Feedback induction of suppressor T-cell activity. J Exp Med 1975; 142:2: 524.
53. Slavin S, Strober S, Fuks Z, Kaplan HS. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 1977; 146: 34.
54. Hodes RJ, Hathcock KS. Regulatory mechanisms in cell mediated immune responses. IV. Evidence for the spontaneous generation of suppressor cells in vitro. Transplantation 1972; 28(5): 430.
55. Waltenbaugh C, Sun L, Lei HY. I-J expression is not associated with murine chromosome 4. Eur J Immunol 1985; 15(9): 922.
56. Jerne K. Towards a network theory of the immune system. Ann Imm (Inst Pasteur) 1974; 125C: 373.
57. Binz H, Wigzell H. Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. I. Demonstration of similar or identical idiotypes on IgG molecules and T cell receptors with specificity for the same alloantigens. J Exp Med 1975; 142: 1231.
58. Rachamim N, Gan J, Segall H, et al. Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation 1998; 65:10: 1386.
59. Kawaguchi S. Induction of tolerance in B-1 cells for bromelain-treated mouse red blood cells by a transient presence of anti-idiotype antibodies in neonatal and adult mice. J Immunol 1998; 160(10): 4796.
60. Lucas AH, Granoff DM. A major crossreactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Expression in relation to age and immunoglobulin G subclass. J Clin Invest 1990; 85: 1158.
61. Kearney JF, Vakil M. Idiotype-directed interactions during ontogeny play a major role in the establishment of the adult B cell repertoire. Immunol Rev 1986; 94: 39.
62. Burrows PD, Cooper MD. B cell development and differentiation. Curr Opin Immunol 1997; 9(2): 239.
63. Mishra N, Kammer GM. Clinical expression of autoimmune diseases in older adults. Clin Geriatr Med 1998; 14(3): 515.
64. Simonsen M. Graft versus host reactions. Their natural history and applicability as tools of research. Progr Allergy 1962; 6: 249.
65. Kelemen E, Szebeni J, Petrányi GG. Graft-versus-host disease in bone marrow transplantation: experimental, laboratory, and clinical contributions of the last few years. Int Arch Allergy Immunol 1993; 102: 309.
66. Carreno M, Mathew JM, Esquenazi V, et al. Phenotypic diversity and possible function of two distinct dendritic cell populations. J Leukocyte Biol 1998; 2: 46.
67. Müller Am, Medvinsky A, Stroudoulis J, Grasveld F, Ozierzak E. Development of Hematopoietic stem cell activity in the mouse embryo. Immunity 1994; 1: 291.
68. Miller RG, Derry H. A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells against self antigens of the nu/nu spleen. J Immunol 1979; 122: 1502.
69. Murase N, Starzl T, Tanabe M, et al. Variable chimerism graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats. Transplantation 1995; 60: 158.
70. Miller R. The veto phenomenon and T cell regulation. Immunol Today 1986; 7: 112.
71. Aranco BA, Vowell RL. MHC linked immune response suppression mediated by T cells bearing I-A encoded determinants. J Immunol 1985; 135: 73.
72. Miller RG. An immunological suppressor cells which inactivates cytotoxic T lymphocyte precursor cells recognizing it. Nature 1980; 287: 544.
73. Fink PJ, Rammensee HG, Bevan MJ. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them. J Immunol 1984; 133: 1775.
74. Muroaka S, Miller RG. Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Exp Med 1980; 152: 54.
75. Muroaka S, Miller RG. Cells in murine fetal liver and in lymphoid colonies grown from fetal liver can suppress generations of cytotoxic T lymphocytes directed against their self antigens. J Immunol 1983; 131: 45.
76. Thomson A, Lu L, Subbotin VMLY, et al. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Transplantation 1995; 59: 544.
77. Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101.
78. Claesson MH, Ropke C. Anti-self suppressive (veto) activity of responder cells in mixed lymphocyte culture. Curr Top Microbial Immunol 1986; 126: 213.
79. Woo J, Lu L, Rao AS, et al. Isolation, phenotype and allostimulatory activity of mouse liver dendritic cells. Transplantation 1994; 58: 484.
80. Verbanac KM, Carver FM, Haisch CE, Thomas J. A role for transforming growth factor-beta in the veto mechanism in transplant tolerance. J Immunol 1994; 57: 893.
81. Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science 1991; 252: 1424.
82. Kaufman CL, Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST. Phenotypic characterization of the novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994; 84(8): 2436.
83. Lu L, Rudert WA, Qian S, et al. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med 1995; 182(2): 379.
84. Fu F, Li Y, Qian S, Lu L, Chambers F, Starzl TE, Fung JJ, Thomson AW. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62(5): 659.
85. Mathew M, Carreno M, Fuller L, et al. Modulatory effects of human donor bone marrow cells on allogeneic cellular immune responses. Transplantation 1997; 63(5): 686.
86. Mathew JM, Carreno M, Zucker K, et al. Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation. Transplantation 1998; 65(7): 947.
87. Carreno M, Esquenazi V, Gomez C, et al. Immunophenotyping and cellular immune responses of cadaver donor bone marrow cells. Transplant Proc 1998; 30: 727.
88. Garcia-Morales R, Carreno M, Mathew J, et al. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-Flow assays in kidney transplant recipients. J Clin. Invest 1997; 99(5): 1118.
89. Ciancio G, Carreno M, Mathew J, et al. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK506 and OKT3 induction therapy. Transplant Proc 1996; 28: 943.
90. Garcia-Morales R, Esquenazi V, Zucker K, et al. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry. Transplantation 1996; 62(8): 1149.
91. Ayoub G, Terasaki P. HLA-DR matching in multicenter, single-typing laboratory data. Transplantation 1982; 33: 515.
92. Pescovitz MD, Thistlethwaite JR Jr, Auchincloss H Jr, et al. Effect of class II antigen matching of renal allograft survival in miniature swine. J Exp Med 1984; 160: 1495.
93. Cobbold SP, Martin G, Qin S, Waldmann H. Monoclonal antibodies to promote marrow engraftment and tissue tolerance. Nature 1986; 373: 164.
94. Reinsmoen NL, Matas AJ. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 1993; 55: 1017.
95. Ciancio G, Morales-Garcia R, Burke GW, et al. Donor bone marrow, chimerism, histocompatibility and renal allograft rejection. Transplant Proc 1999; 31: 679.
96. Pham SM, Rao AS, Zeevi A, et al. Effects of donor bone marrow infusion in clinical lung transplantation. Ann Thorac Surg 2000 (in press).
97. Garcia-Morales R, Carreno M, Mathew J, et al. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. Transplantation 1998; 65: 956.
98. Jin Y, Fuller L, Mathew JM, Esquenazi V, Tzakis AG, Miller J. Bone marrow cells inhibit the generation of EBV specific CTL. FASEB J 1999; 13: A983.
99. Swain SL, Bradley LM, Croft M, et al. Helper T cell subsets: Phenotype, function and the role of lymphokines in regulating their development. Immunol Rev 1991; 123: 115.
100. Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 1990; 63: 1249.
101. Russell JH, White CL, Loh DY, Meleedy-Rey P. Receptor stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci USA 1991; 88: 2151.
102. Rocha B, Von Boehmer H. Peripheral selection of the T cell repertoire. Science 1991; 251: 1225.
103. Huang L, Crispe NI. Superantigen-driven peripheral deletion of T cells: apoptosis occurs in cells that have lost αβ T cell receptors. J Immunol 1993; 151: 1844.